Table 1:

Preoperative characteristics

Group 1 (n = 19)Group 2 (n = 13)P-value
Age (years)65.9 ± 12.461.4 ± 10.20.2019
Male11 (61.1)6 (60.0)0.2899
BMI (kg/m2)27.1 ± 4.924.99 ± 7.20.2646
Diabetes1 (5.5)3 (23.1)0.4420
Hypertension14 (77.78)8 (61.5)0.7889
Hyperlipidaemia14 (77.78)5 (38.5)0.3124
Smoking7 (38.89)6 (46.2)0.6309
COPD3 (16.67)2 (15.4)1.0000
PVD8 (44.44)6 (46.2)0.7248
Renal insufficiency01 (7.7)0.5882
Previous MI13 (72.22)4 (30.1)0.2160
Previous CABG3 (16.67)00.0441
Previous PCI5 (27.78)1 (7.7)0.0702
CCS >38 (44.44)6 (46.2)0.1027
3Vx3 (16.67)1 (7.7)0.354
LMCA9 (50.0)5 (38.5)0.986
Normal LVEF15 (83.3)8 (61.5)0.892
ASA3.33 ± 0.693.67 ± 0.50.6592
EuroSCORE10.16 ± 6.797.8 ± 7.60.125
Group 1 (n = 19)Group 2 (n = 13)P-value
Age (years)65.9 ± 12.461.4 ± 10.20.2019
Male11 (61.1)6 (60.0)0.2899
BMI (kg/m2)27.1 ± 4.924.99 ± 7.20.2646
Diabetes1 (5.5)3 (23.1)0.4420
Hypertension14 (77.78)8 (61.5)0.7889
Hyperlipidaemia14 (77.78)5 (38.5)0.3124
Smoking7 (38.89)6 (46.2)0.6309
COPD3 (16.67)2 (15.4)1.0000
PVD8 (44.44)6 (46.2)0.7248
Renal insufficiency01 (7.7)0.5882
Previous MI13 (72.22)4 (30.1)0.2160
Previous CABG3 (16.67)00.0441
Previous PCI5 (27.78)1 (7.7)0.0702
CCS >38 (44.44)6 (46.2)0.1027
3Vx3 (16.67)1 (7.7)0.354
LMCA9 (50.0)5 (38.5)0.986
Normal LVEF15 (83.3)8 (61.5)0.892
ASA3.33 ± 0.693.67 ± 0.50.6592
EuroSCORE10.16 ± 6.797.8 ± 7.60.125

Data are presented as mean ± SD or number (%).

ASA: American Society of Anaesthesiologists; BMI: body mass index (kg/m2); CABG: coronary artery bypass graft; CCS: Canadian Cardiovascular Society; COPD: chronic congestive pulmonary disease; LMCA: left main coronary artery; LVEF: left ventricular ejection fraction; MI: myocardial infarction; PCI: percutaneous coronary intervention; PVD: peripheral vascular disease; 3Vx: three vessels coronary artery disease.

Table 1:

Preoperative characteristics

Group 1 (n = 19)Group 2 (n = 13)P-value
Age (years)65.9 ± 12.461.4 ± 10.20.2019
Male11 (61.1)6 (60.0)0.2899
BMI (kg/m2)27.1 ± 4.924.99 ± 7.20.2646
Diabetes1 (5.5)3 (23.1)0.4420
Hypertension14 (77.78)8 (61.5)0.7889
Hyperlipidaemia14 (77.78)5 (38.5)0.3124
Smoking7 (38.89)6 (46.2)0.6309
COPD3 (16.67)2 (15.4)1.0000
PVD8 (44.44)6 (46.2)0.7248
Renal insufficiency01 (7.7)0.5882
Previous MI13 (72.22)4 (30.1)0.2160
Previous CABG3 (16.67)00.0441
Previous PCI5 (27.78)1 (7.7)0.0702
CCS >38 (44.44)6 (46.2)0.1027
3Vx3 (16.67)1 (7.7)0.354
LMCA9 (50.0)5 (38.5)0.986
Normal LVEF15 (83.3)8 (61.5)0.892
ASA3.33 ± 0.693.67 ± 0.50.6592
EuroSCORE10.16 ± 6.797.8 ± 7.60.125
Group 1 (n = 19)Group 2 (n = 13)P-value
Age (years)65.9 ± 12.461.4 ± 10.20.2019
Male11 (61.1)6 (60.0)0.2899
BMI (kg/m2)27.1 ± 4.924.99 ± 7.20.2646
Diabetes1 (5.5)3 (23.1)0.4420
Hypertension14 (77.78)8 (61.5)0.7889
Hyperlipidaemia14 (77.78)5 (38.5)0.3124
Smoking7 (38.89)6 (46.2)0.6309
COPD3 (16.67)2 (15.4)1.0000
PVD8 (44.44)6 (46.2)0.7248
Renal insufficiency01 (7.7)0.5882
Previous MI13 (72.22)4 (30.1)0.2160
Previous CABG3 (16.67)00.0441
Previous PCI5 (27.78)1 (7.7)0.0702
CCS >38 (44.44)6 (46.2)0.1027
3Vx3 (16.67)1 (7.7)0.354
LMCA9 (50.0)5 (38.5)0.986
Normal LVEF15 (83.3)8 (61.5)0.892
ASA3.33 ± 0.693.67 ± 0.50.6592
EuroSCORE10.16 ± 6.797.8 ± 7.60.125

Data are presented as mean ± SD or number (%).

ASA: American Society of Anaesthesiologists; BMI: body mass index (kg/m2); CABG: coronary artery bypass graft; CCS: Canadian Cardiovascular Society; COPD: chronic congestive pulmonary disease; LMCA: left main coronary artery; LVEF: left ventricular ejection fraction; MI: myocardial infarction; PCI: percutaneous coronary intervention; PVD: peripheral vascular disease; 3Vx: three vessels coronary artery disease.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close